Locating Nociceptive Stimuli on Digital Body Chart

Sponsor
IRCCS San Raffaele (Other)
Overall Status
Completed
CT.gov ID
NCT03463109
Collaborator
(none)
72
1
2
21.2
3.4

Study Details

Study Description

Brief Summary

Digital body charts are used to assess the pain experience in people with pain. People are asked to report their pain by shading a human body template on a digital tablet. The aim of this study is to investigate whether people with chronic low back pain, compared to healthy volunteers, consistently locate on a digital body chart all nociceptive stimuli induced in the lumbar region.

Condition or Disease Intervention/Treatment Phase
  • Other: Electrocutaneous stimulation
  • Other: Assessment + Electrocutaneous stimulation
N/A

Detailed Description

Healthy volunteers and people presenting chronic low back pain, will be recruited. A standardized grid will be drawn over the participants' lumbar region. Circular electrodes, connected to a constant current stimulator, will be applied at points on the grid. All participants will be blinded to the electrode locations. Painful electrocutaneous stimuli will be randomly delivered for each electrode. Participants will be instructed to draw with a stylus pen on a digital body chart displayed on a tablet where they will perceive each painful stimulation.

The body chart will be centred on a canvas 768x1024 pixels (pxl), and pain location will be defined by X and Y coordinates. The consistency in reporting the location of each painful stimulation will be described through coordinates.

In addition, only people presenting chronic low back pain will be asked to provide information about their lifestyle, level of disability, actual pain and general pain, assessment of kinesiophobia and health status.

Study Design

Study Type:
Interventional
Actual Enrollment :
72 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The same procedure will be used for people with chronic low back pain and for healthy volunteers.The same procedure will be used for people with chronic low back pain and for healthy volunteers.
Masking:
Single (Participant)
Masking Description:
Every participant will recive stimulation on his back in a pre-defined random order.
Primary Purpose:
Basic Science
Official Title:
Locating Nociceptive Stimuli Applied to the Lumbar Region in Healthy Subjects and in Subjects With Chronic Low Back Pain
Actual Study Start Date :
Apr 27, 2018
Actual Primary Completion Date :
Jan 31, 2020
Actual Study Completion Date :
Jan 31, 2020

Arms and Interventions

Arm Intervention/Treatment
Other: Healthy Volunteers

Electrocutaneous stimulation. A standardized grid will be drawn over the participants' lumbar region. Circular electrodes, connected to a constant current stimulator, will be applied at points on the grid selected at random. Participants will be blinded to the electrode locations. Sets of painful electrocutaneous stimuli will be randomly delivered for each electrode. Participants will be instructed to draw with a stylus pen on a digital body chart displayed on a tablet the location on which they will perceive each painful stimulation.

Other: Electrocutaneous stimulation
Painful electrocutaneous stimuli will be randomly delivered to electrodes positioned in a random order on the participants' back. Participants will be instructed to draw with a stylus pen on a digital body chart displayed on a tablet where they will perceive each painful stimulation.

Other: Chronic Low Back Pain

Assessment + Electrocutaneous stimulation. Patients with chronic low back pain will be asked to provide information about their lifestyle, level of disability, current pain, general pain and to undergo an assessment of kinesiophobia and health status. After the assessment, a standardized grid will be drawn over the patients' lumbar region. Circular electrodes, connected to a constant current stimulator, will be applied at points on the grid. Patients will be blinded to the electrode locations. Sets of painful electrocutaneous stimuli will be randomly delivered for each electrode. Patients will be instructed to draw with a stylus pen on a digital body chart displayed on a tablet where they will perceive each painful stimulation.

Other: Assessment + Electrocutaneous stimulation
Patients will be asked to provide information about their lifestyle, level of disability, actual pain and general pain, assessment of kinesiophobia and health status. Subsequently, painful electrocutaneous stimuli will be randomly delivered to electrodes positioned in a random order on the patients' back. Patients will be instructed to draw with a stylus pen on a digital body chart displayed on a tablet where they will perceive each painful stimulation.

Outcome Measures

Primary Outcome Measures

  1. The distance from marked points to the representation of the stimulated point on the digital body chart. [Immediately after the electrocutaneous stimulation]

Secondary Outcome Measures

  1. Oswestry Disability Index (ODI) score [Before electrocutaneous stimulation]

    The Oswestry Disability Index is a tool for the assessment of a patient's functional disability. It is a self-completed questionnaire contains ten topics concerning intensity of pain, lifting, ability to care for oneself, ability to walk, ability to sit, sexual function, ability to stand, social life, sleep quality, and ability to travel. Each topic category is followed by six statements describing different scenarios in the patient's life relating to the topic. The patient then checks the statement which most closely resembles their situation. Each question is scored on a scale of 0-5, where 0 indicates less amount of disability and 5 indicates most severe disability. The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100). Zero is equated with no disability and 100 is the maximum disability possible. Italian validated version of the scale will be used.

  2. Current pain level on Visual Analogue Scale (VAS, 0-10 cm) [Before electrocutaneous stimulation]

    The patient will be asked to draw a vertical line on a horizontal 10 cm line, where he/she felt the current pain intensity would be better represented, in a range from the left end of the line indicating "no pain" corresponding to 0 cm to the right one indicating "worst pain imaginable" corresponding to 10 cm. The total score of the scale ranges from 0 = "no pain" to 10 = "worst pain imaginable".

  3. Recent pain (last week) level on Visual Analogue Scale (VAS, 0-10 cm) [Before electrocutaneous stimulation]

    The patient will be asked to draw a vertical line on a horizontal 10 cm line, where he/she felt the recent pain intensity would be better represented, in a range from the left end of the line indicating "no pain" corresponding to 0 cm to the right one indicating "worst pain imaginable" corresponding to 10 cm.

  4. Tampa Scale for Kinesiophobia (TSK-13) [Before electrocutaneous stimulation]

    The Tampa Scale of Kinesiophobia (TSK) is a 13 item scale developed to measure the fear of movement (kinesiophobia) related to chronic lower back pain. Respondents are asked to rate each item on a 4-point Likert scale, ranging from 1 (strongly disagree) to 4 (strongly agree). The subscale ranges scores are 13-22 suggesting "subclinical level of kinesiophobia", 23-32 suggesting "mild level of kinesiophobia", 33-42 suggesting "moderate level of kinesiophobia" and 43-52 suggesting "severe level of kinesiophobia". Italian validated version of the scale will be used.

  5. The Short Form Health Survey (SF-36) [Before electrocutaneous stimulation]

    The Short Form Health Survey (SF-36) is a 36 item questionnaire which measures the quality of life across eight domains, which are both physically and emotionally based. High scores define a more favorable health state. Italian validated version of the scale will be used.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Chronic low back pain (duration more than three months)
Exclusion Criteria:
  • denial of informed consent;

  • presence of pacemaker;

  • pregnancy or possible pregnancy status;

  • lumbar surgery (spinal fusion);

  • documented degenerative pathology of the central nervous system;

  • documented concomitant pathology altering sensitivity (e.g. diabetes, fibromyalgia);

  • reduced motor control of the dominant hand (reported by every subject as conditioning the writing and therefore the ability to compile the body chart);

  • presence of skin moles and/or scars on the back that may interfere with the conduction of the electrical stimulus.

Contacts and Locations

Locations

Site City State Country Postal Code
1 San Raffaele Scientific Institute Milan Italy 20132

Sponsors and Collaborators

  • IRCCS San Raffaele

Investigators

  • Study Director: Marco Barbero, University of Applied Sciences and Arts of Southern Switzerland

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alessandra Raschi, Principal Investigator, IRCCS San Raffaele
ClinicalTrials.gov Identifier:
NCT03463109
Other Study ID Numbers:
  • Localizzazione Stimoli
First Posted:
Mar 13, 2018
Last Update Posted:
Mar 23, 2020
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Alessandra Raschi, Principal Investigator, IRCCS San Raffaele
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 23, 2020